HIGHLIGHTS
- who: Lei Xu and collaborators from the Laboratory Animal Center, Chongqing Medical University, Chongqing, China have published the article: Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma, in the Journal: (JOURNAL) of 23/09/2021
- what: The findings from the analysis showed that CHD5 was differentially expressed in the tumor tissues as compared to the normal tissues. Currently, the CNV, TMB and MSI of CHD5 are less reported in these cancers, and the study provides new insights into the mutational landscape in these cancers. This study shows that CHD5 expression affects glioma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.